Bicanic, Tihana

Tackling the emerging threat of antifungal resistance to human health

Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 1,179

Cryptococcus: from environmental saprophyte to global pathogen

May, R. C., Stone, N. R. H., Wiesner, D. L., Bicanic, T., & Nielsen, K. (2016) · Nature Reviews Microbiology

Fungal Infections and StudiesBacterial Infections and Vaccines

Cited by 541

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 537

Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

Jarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., et al. (2014) · Clinical Infectious Diseases

Fungal Infections and StudiesInfectious Diseases and Tuberculosis

Cited by 367

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern, D. J., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., Angus, B., Ansari, M. A., Arancibia-Cárcamo, C. V., Aschenbrenner, D., Attar, M., et al. (2022) · Cell

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 328

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial

Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 290

Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients

Bicanic, T., Muzoora, C., Brouwer, A. E., Meintjes, G., Longley, N., Taseera, K., Rebe, K., Loyse, A., Jarvis, J., Bekker, L., et al. (2009) · Clinical Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 227

The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis

Dambuza, I. M., Drake, T., Chapuis, A., Zhou, X., Correia, J., Taylor-Smith, L., LeGrave, N., Rasmussen, T., Fisher, M. C., Bicanic, T., et al. (2018) · PLoS Pathogens

Fungal Infections and StudiesFungal and yeast genetics research

Cited by 182

Invasive candidiasis in critical care: challenges and future directions

Logan, C., Martin-Loeches, I., & Bicanic, T. (2020) · Intensive Care Medicine

Antifungal resistance and susceptibilityNosocomial Infections in ICU

Cited by 180

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis

Stone, N. R. H., Rhodes, J., Fisher, M. C., Mfinanga, S., Kivuyo, S., Rugemalila, J., Segal, E. S., Needleman, L., Molloy, S. F., Kwon-Chung, J., et al. (2019) · Journal of Clinical Investigation

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 167

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 152

Cerebrospinal Fluid Cytokine Profiles Predict Risk of Early Mortality and Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis

Jarvis, J. N., Meintjes, G., Bicanic, T., Buffa, V., Hogan, L., Mo, S., Tomlinson, G., Kropf, P., Noursadeghi, M., & Harrison, T. S. (2015) · PLOS Pathogens

Fungal Infections and StudiesInfectious Diseases and Tuberculosis

Cited by 150

Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study

Salmanton-García, J., Cornely, O. A., Stemler, J., Barać, A., Steinmann, J., Siváková, A., Akalin, E. H., Arikan-Akdagli, S., Loughlin, L., Toscano, C., et al. (2024) · Journal of Infection

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 127

A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection

Rhodes, J., Beale, M. A., Vanhove, M., Jarvis, J. N., Kannambath, S., Simpson, J. A., Ryan, A., Meintjes, G., Harrison, T. S., Fisher, M. C., et al. (2017) · G3 Genes|Genomes|Genetics

Fungal Infections and StudiesGenetic diversity and population structure

Cited by 100

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries

Loyse, A., Burry, J., Cohn, J., Ford, N., Chiller, T., Ribeiro, I., Koulla-Shiro, S., Mghamba, J., Ramadhani, A., Nyirenda, R., et al. (2019) · The Lancet Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 90

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance

Hope, W., Stone, N. R. H., Johnson, A., McEntee, L., Farrington, N., Santoro-Castelazo, A., Liu, X., Lucaci, A., Hughes, M., Oliver, J. D., et al. (2019) · mBio

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 70